This country profile provides an overview of Liberia’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
84%
Blinding trachoma
N/A
Intestinal worms
93%
Bilharzia
89%
River blindness
84%
2.98 million
people received treatment in Liberia in 2019
197k
people did not receive treatment in Liberia in 2019
Elephantiasis
Treatment coverage increased from 68% in 2018 to 84% in 2019.
People needing treatment
2.96m
People receiving treatment
2.5m
Blinding trachoma
Liberia does not require mass treatment for blinding trachoma.
Intestinal worms
Treatment coverage increased from 76% in 2018 to 93% in 2019.
Pre-sch and school-aged children needing treatment
903k
Pre-school and school-aged children receiving treatment
839k
Bilharzia
Treatment coverage decreased from 97% in 2018 to 89% in 2019.
School-aged children needing treatment
605k
School-aged children receiving treatment
539k
River blindness
Treatment coverage increased from 69% in 2018 to 84% in 2019.
People needing treatment
3.18m
People receiving treatment
2.66m
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Liberia.